Jim Nelson

Intellectual Property

About Jim Nelson

Schwegman, Lundberg & Woessner

121 S 8th St #1600 Minneapolis, Minnesota 55402

jnelson@slwip.com

(612) 373-6939

View Lawyer's Website

Topics Addressed by This Lawyer

BioSimilars

Merrifield Synthesis

Impact of US Hatch Waxman Act 1984

Biologics Price Competition and Innovation Act

Are BioSimilars Being Approved in the US?

Litigation and BioSimilar Patenting

Claim Maps and BioSimilars

Approvals of BioSimilars in Europe

Who Determines Substitution Factors?

What is a BioSimilar Product Under US Law?

What is a BioSimilar?

How to Navigate BioSimilar Challenges

BioSimilar Patenting Litigation Involving Large Amounts of Money

FDA Guidelines for Demonstrating Biosimilarity

Demonstrating BioSimilarity Under U.S. Law

Sponsor

Naming Problems with BioSimilars

Biologics vs Small Molecules

Why Are Biologicals so Important?

Top Rated Intellectual Property Law

Experience

Rewards of the Practice

Technical Background

Top Rated Intellectual Property Law Firm

Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals